Androgen Deprivation Therapy in High-Risk Prostate Cancer

被引：0

作者：

Buyyounouski, Mark K. ^{[1
]}

机构：

[1] Fox Chase Canc Ctr, Dept Radiat Oncol, Philadelphia, PA 19111 USA

来源：

ONCOLOGY-NEW YORK | 2010年 / 24卷 / 09期

关键词：

RADIOTHERAPY;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：806 / 809

页数：2

共 50 条

[31] Adjuvant Radiation Therapy, Androgen Deprivation, and Docetaxel for High-Risk Prostate Cancer Postprostatectomy: Results of NRG Oncology/RTOG Study 0621 [J].

Hurwitz, Mark D. ;

Harris, Jonathan ;

Sartor, Oliver ;

Xiao, Ying ;

Shayegan, Bobby ;

Sperduto, Paul W. ;

Badiozamani, Kasra R. ;

Lawton, Colleen A. F. ;

Horwitz, Eric M. ;

Michalski, Jeff M. ;

Roof, Kevin ;

Beyer, David C. ;

Zhang, Qiang ;

Sandler, Howard M. .

CANCER, 2017, 123 (13) :2489-2496

[32] DOSE-ESCALATED RADIOTHERAPY FOR HIGH-RISK PROSTATE CANCER: OUTCOMES IN MODERN ERA WITH SHORT-TERM ANDROGEN DEPRIVATION THERAPY [J].

Liauw, Stanley L. ;

Stadler, Walter M. ;

Correa, David ;

Weichselbaum, Ralph R. ;

Jani, Ashesh B. .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 77 (01) :125-130

[33] Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer [J].

Lin, Jianqing ;

Den, Robert B. ;

Greenspan, Jacob ;

Showalter, Timothy N. ;

Hoffman-Censits, Jean H. ;

Lallas, Costas D. ;

Trabulsi, Edouard J. ;

Gomella, Leonard G. ;

Hurwitz, Mark D. ;

Leiby, Benjamin ;

Dicker, Adam P. ;

Kelly, W. Kevin .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (05) :939-947

[34] Interaction of adjuvant androgen deprivation therapy with patient comorbidity status on overall survival after radical prostatectomy for high-risk prostate cancer [J].

Linder, Brian J. ;

Boorjian, Stephen A. ;

Umbreit, Eric C. ;

Carlson, Rachel E. ;

Rangel, Laureano J. ;

Bergstralh, Eric J. ;

Karnes, R. Jeffrey .

INTERNATIONAL JOURNAL OF UROLOGY, 2013, 20 (08) :798-805

[35] Radical prostatectomy vs radiation therapy and androgen-suppression therapy in high-risk prostate cancer [J].

Westover, Kenneth ;

Chen, Ming-Hui ;

Moul, Judd ;

Robertson, Cary ;

Polascik, Thomas ;

Dosoretz, Daniel ;

Katin, Michael ;

Salenius, Sharon ;

D'Amico, Anthony V. .

BJU INTERNATIONAL, 2012, 110 (08) :1116-1121

[36] Long-term outcome of high-risk prostate cancer treated with brachytherapy combined with external-beam radiation therapy and androgen deprivation therapy [J].

Chen, Jian ;

Yan, Wei-gang ;

Li, Han-zhong ;

Ji, Zhi-gang ;

Zhou, Yi ;

Zhou, Zhi-en ;

Mai, Zhi-peng .

TUMORI JOURNAL, 2014, 100 (05) :524-528

[37] Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer? [J].

Nguyen, KH ;

Horwitz, EM ;

Hanlon, AL ;

Uzzo, RG ;

Pollack, A .

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2003, 57 (02) :377-383

[38] Androgen deprivation therapy as backbone therapy in the management of prostate cancer [J].

Merseburger, Axel S. ;

Alcaraz, Antonio ;

von Klot, Christoph A. .

ONCOTARGETS AND THERAPY, 2016, 9 :7263-7274

[39] Androgen deprivation therapy for prostate cancer: New developments [J].

Rabbani, F ;

Fair, WR .

INFECTIONS IN UROLOGY, 1999, 12 (04) :104-+

[40] Androgen Deprivation Therapy and Definitive Radiotherapy for Prostate Cancer [J].

Mendenhall, William M. ;

Henderson, Randal H. ;

Hoppe, Bradford S. ;

Nichols, Romaine Charles ;

Mendenhall, Nancy P. .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (05) :530-534

← 1 2 3 4 5 →